Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA

被引:167
作者
Bourgeois, CF [1 ]
Lejeune, F
Stévenin, J
机构
[1] ULP, Inst Gent & Biol Mol & Cellulaire, CNRS, INSERM,CU Strasbourg, F-67404 Illkirch Graffenstaden, France
[2] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA
来源
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 78 | 2004年 / 78卷
基金
澳大利亚研究理事会;
关键词
D O I
10.1016/S0079-6603(04)78002-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing of pre-messenger RNA (pre-mRNA) is a highly regulated process that allows expansion of the potential of expression of the genome in higher eukaryotes and involves many factors. Among them, the family of the serine- and arginine-rich proteins (SR proteins) plays a pivotal role: it has essential functions during spliceosome assembly and also interacts with RNA regulatory sequences on the pre-mRNA as well as with multiple cofactors. Collectively, SR proteins, because of their capacity to recognize multiple RNA sequences with a broad specificity, are at the heart of the regulation pathways that lead to the choice of alternative splice sites. Moreover, a growing body of evidence shows that the mechanisms of splicing regulation are not limited to the basic involvement of cis- and trans-acting factors at the pre-mRNA level, but result from intricate pathways, initiated sometimes by stimuli that are external to the cell and integrate SR proteins (and other factors) within an extremely sophisticated network of molecular machines associated with one another. This review focuses on the molecular aspects of the functions of SR proteins. In particular, we discuss the different ways in which SR proteins manage to achieve a high level of specificity in splicing regulation, even though they are also involved in the constitutive reaction. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:37 / 88
页数:52
相关论文
共 238 条
[61]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437
[62]  
Fetzer S, 1997, RNA, V3, P344
[63]   GENERAL SPLICING FACTORS SF2 AND SC35 HAVE EQUIVALENT ACTIVITIES INVITRO, AND BOTH AFFECT ALTERNATIVE 5' AND 3' SPLICE SITE SELECTION [J].
FU, XD ;
MAYEDA, A ;
MANIATIS, T ;
KRAINER, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11224-11228
[64]   SPECIFIC COMMITMENT OF DIFFERENT PREMESSENGER RNAS TO SPLICING BY SINGLE SR PROTEINS [J].
FU, XD .
NATURE, 1993, 365 (6441) :82-85
[65]   FACTOR REQUIRED FOR MAMMALIAN SPLICEOSOME ASSEMBLY IS LOCALIZED TO DISCRETE REGIONS IN THE NUCLEUS [J].
FU, XD ;
MANIATIS, T .
NATURE, 1990, 343 (6257) :437-441
[66]   Multiple roles for SR proteins in trans splicing [J].
Furuyama, S ;
Bruzik, JP .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5337-5346
[67]   The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20 [J].
Galiana-Arnoux, D ;
Lejeune, F ;
Gesnel, MC ;
Stevenin, J ;
Breathnach, R ;
Del Gatto-Konczak, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :32943-32953
[68]   The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A [J].
Gallego, ME ;
Gattoni, R ;
Stevenin, J ;
Marie, J ;
ExpertBezancon, A .
EMBO JOURNAL, 1997, 16 (07) :1772-1784
[69]   PRIMARY STRUCTURE OF THE HUMAN SPLICING FACTOR ASF REVEALS SIMILARITIES WITH DROSOPHILA REGULATORS [J].
GE, H ;
ZUO, P ;
MANLEY, JL .
CELL, 1991, 66 (02) :373-382
[70]   A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2 [J].
Ge, H ;
Si, YZ ;
Wolffe, AP .
MOLECULAR CELL, 1998, 2 (06) :751-759